(R)-ketamine nasal spray (HS-10345)
/ Jiangsu Hansoh Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
March 09, 2023
A Study To Evaluate The Safety, Tolerability And Pharmacokinetics of HS-10345 In Treatment-Resistant Depression
(clinicaltrials.gov)
- P1 | N=12 | Completed | Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. | Active, not recruiting ➔ Completed
Trial completion • CNS Disorders • Depression • Mood Disorders • Psychiatry
June 15, 2022
A Study To Evaluate The Safety, Tolerability And Pharmacokinetics of HS-10345 In Treatment-Resistant Depression
(clinicaltrials.gov)
- P1 | N=12 | Active, not recruiting | Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. | Recruiting ➔ Active, not recruiting | N=24 ➔ 12 | Trial completion date: Apr 2022 ➔ Jul 2022
Enrollment change • Enrollment closed • Trial completion date • CNS Disorders • Depression • Mood Disorders • Psychiatry
1 to 2
Of
2
Go to page
1